Canada’s patent ‘utility’ regime on trial: Adrienne Blanchard for the MLI IP newsletter
The Supreme Court’s decision to hear AstraZeneca’s appeal and this month’s NAFTA hearings on an Eli Lilly complaint shine a ...
Tag: IP newsletter
Dodged bullet or missed opportunity with CHEO settlement?: Richard Owens for the MLI IP newsletter
While there was certainly a win on the costs of genetic testing, the long-term effects of Transgenomic’s departure from the ...
Stop the TPP-IP media pile-on: Richard Owens for the MLI IP newsletter
It has become fashionable to declare the Trans-Pacific Partnership intellectual property provisions a disaster for innovation in Canada, writes Richard ...
Top News
-
There’s no reason to believe CTV conspired against Pierre Poilievre. Here’s what the network actually did wrong: Peter Menzies in the Toronto Star
-
How post-colonialism is fuelling antisemitic protests across the West: Obaid Omer for Inside Policy
-
What Mark Carney should really tell the floundering federal government: Fen Osler Hampson and Tim Sargent in the Hub
-
Canada’s NORAD modernization plan hinges on the North’s expertise and innovation: Lee Carson and Patrick Duxbury for Inside Policy
-
Israel, Antisemitism, and a New Middle East: Einat Wilf in Conversation with Casey Babb
